These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30473490)

  • 21. Brain Plasma Membrane Monoamine Transporter in Health and Disease.
    Vieira LS; Wang J
    Handb Exp Pharmacol; 2021; 266():253-280. PubMed ID: 33751232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: a comparison to human alpha 1- and alpha 2-adrenoceptor subtypes.
    Amphoux A; Millan MJ; Cordi A; Bönisch H; Vialou V; Mannoury la Cour C; Dupuis DS; Giros B; Gautron S
    Eur J Pharmacol; 2010 May; 634(1-3):1-9. PubMed ID: 20170649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine.
    Sun S; Wang K; Lei H; Li L; Tu M; Zeng S; Zhou H; Jiang H
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():1-6. PubMed ID: 24246570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy.
    Daws LC
    Pharmacol Ther; 2009 Jan; 121(1):89-99. PubMed ID: 19022290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of organic cations with a newly identified plasma membrane monoamine transporter.
    Engel K; Wang J
    Mol Pharmacol; 2005 Nov; 68(5):1397-407. PubMed ID: 16099839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereoselective Inhibition of High- and Low-Affinity Organic Cation Transporters.
    Gebauer L; Jensen O; Rafehi M; Brockmöller J
    Mol Pharm; 2023 Dec; 20(12):6289-6300. PubMed ID: 37962560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Polytox" synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux.
    Mayer FP; Schmid D; Holy M; Daws LC; Sitte HH
    Neurochem Int; 2019 Feb; 123():7-12. PubMed ID: 30248432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overlap and Specificity in the Substrate Spectra of Human Monoamine Transporters and Organic Cation Transporters 1, 2, and 3.
    Gebauer L; Jensen O; Neif M; Brockmöller J; Dücker C
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organic cation transporters in psychiatric and substance use disorders.
    Honan LE; Fraser-Spears R; Daws LC
    Pharmacol Ther; 2024 Jan; 253():108574. PubMed ID: 38072333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic Properties and Pharmacological Modulation of High- and Low-Affinity Dopamine Transport in Striatal Astrocytes of Adult Rats.
    Sočan V; Dolinar K; Kržan M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereoselectivity in the Membrane Transport of Phenylethylamine Derivatives by Human Monoamine Transporters and Organic Cation Transporters 1, 2, and 3.
    Gebauer L; Rafehi M; Brockmöller J
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations.
    Zhou M; Duan H; Engel K; Xia L; Wang J
    Drug Metab Dispos; 2010 Oct; 38(10):1798-805. PubMed ID: 20592246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene.
    Duan H; Wang J
    J Biol Chem; 2013 Feb; 288(5):3535-44. PubMed ID: 23255610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of murine polyspecific monoamine transporters.
    Miura Y; Yoshikawa T; Naganuma F; Nakamura T; Iida T; Kárpáti A; Matsuzawa T; Mogi A; Harada R; Yanai K
    FEBS Open Bio; 2017 Feb; 7(2):237-248. PubMed ID: 28174689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General Overview of Organic Cation Transporters in Brain.
    Koepsell H
    Handb Exp Pharmacol; 2021; 266():1-39. PubMed ID: 33782773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of organic cation transporters (OCTs) in the brain.
    Couroussé T; Gautron S
    Pharmacol Ther; 2015 Feb; 146():94-103. PubMed ID: 25251364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at the blood-brain barrier and its implications to the transport of neurotoxins.
    Wu KC; Lu YH; Peng YH; Hsu LC; Lin CJ
    J Neurochem; 2015 Dec; 135(6):1178-88. PubMed ID: 26376205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanism of histamine clearance by primary human astrocytes.
    Yoshikawa T; Naganuma F; Iida T; Nakamura T; Harada R; Mohsen AS; Kasajima A; Sasano H; Yanai K
    Glia; 2013 Jun; 61(6):905-16. PubMed ID: 23505051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncovering Functional Contributions of PMAT (
    Beaver JN; Weber BL; Ford MT; Anello AE; Kassis SK; Gilman TL
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.